Home  |  Contact

UniProtKB/Swiss-Prot P36021: Variant p.Gly484Asp

Monocarboxylate transporter 8
Gene: SLC16A2
Variant information

Variant position:  484
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Aspartate (D) at position 484 (G484D, p.Gly484Asp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to medium size and acidic (D)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MCT8 deficiency; does not affect homodimerization activity; impaired thyroid hormone transporter activity; impaired localization to the cell membrane.
Any additional useful information about the variant.



Sequence information

Variant position:  484
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  539
The length of the canonical sequence.

Location on the sequence:   PIAGLLRNCFGDYHVAFYFA  G VPPIIGAVILFFVPLMHQRM
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PIAGLLRNCFGDYHVAFYFAGVPPIIGAVILFFVPLMHQRM

Mouse                         PIAGLLRNCFGDYHVAFYFAGVPPIIGAVILFFVPLMHQRM

Rat                           PIAGLLRNCFGNYHVAFYFAGVPPIIGAVILFFVPLMHQRM

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 539 Monocarboxylate transporter 8
Transmembrane 478 – 498 Helical
Mutagenesis 490 – 490 G -> A. No effect on thyroid hormone (TH) transport.


Literature citations

Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
Kersseboom S.; Kremers G.J.; Friesema E.C.; Visser W.E.; Klootwijk W.; Peeters R.P.; Visser T.J.;
Mol. Endocrinol. 27:801-813(2013)
Cited for: FUNCTION; SUBCELLULAR LOCATION; VARIANTS MCT8 DEFICIENCY ARG-147; CYS-208; LEU-247; VAL-379; LEU-463 AND ASP-484; CHARACTERIZATION OF VARIANTS MCT8 DEFICIENCY ARG-147; CYS-208; LEU-247; VAL-379; LEU-463 AND ASP-484;

Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations.
Fischer J.; Kleinau G.; Mueller A.; Kuehnen P.; Zwanziger D.; Kinne A.; Rehders M.; Moeller L.C.; Fuehrer D.; Grueters A.; Krude H.; Brix K.; Biebermann H.;
J. Mol. Endocrinol. 54:39-50(2015)
Cited for: VARIANTS MCT8 DEFICIENCY THR-150; HIS-197; CYS-371 AND ASP-484; CHARACTERIZATION OF VARIANTS MCT8 DEFICIENCY PHE-120; THR-150; VAL-150; PHE-156 DEL; MET-161; HIS-197; TRP-360; CYS-371 PRO-397; PRO-438; ASP-484 AND PRO-494; SUBUNIT; SUBCELLULAR LOCATION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.